Skip to main content
Caplight Logo









EXORPHIA Inc.

EXORPHIA Inc.

Private
TokyoHealthcare & Life Scienceshttps://exorphia.com/

Last Round

Grant

Dec 16, 2024

Total Funding Raised

$10.4M

Company Overview

EXORPHIA Inc. is a biotechnology company that develops innovative exosome-based therapeutics to address unmet medical needs.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Medical Devices

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

exosome therapeuticsextracellular vesiclesEVsdrug discoveryregenerative medicinecell-free therapyengineered EVsdrug licensinganti-inflammatory therapeuticsanti-fibrotic therapeuticsexosome purificationinfertility treatmentlung disordersin vitro fertilizationIVFmesenchymal stem cellsMSCsveterinary medicinenasal vaccine

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

EXORPHIA Inc. Comparables

Compare EXORPHIA Inc. with similar companies based on industry and business-model similarity.

EXORPHIA Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
EVerMed, Inc.
87%
BREXOGEN Inc.
85%
SHIFTBIO
79%

EXORPHIA Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantDec 16, 2024
VC RoundDec 1, 2024
StrategicMar 1, 2024
Series AJul 1, 2023
Pre SeedMay 19, 2022
Seed
Apr 12, 2021

EXORPHIA Inc. Investors

Notable investors and investment history

EXORPHIA Inc. investors
InvestorRounds
Coral CapitalSeries A
Keio Innovation InitiativeSeries A, Pre Seed
New Energy and Industrial Technology Development OrganizationGrant
Coral CapitalVC Round
D3 LLCSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 22, 2025

    Monthly visitors increased 116% MoM.

  • Dec 16, 2024

    $1.07M grant received from New Energy and Industrial Technology Development Organization.

EXORPHIA Inc. Filings

Explore SEC and related filing metadata, where available.

EXORPHIA Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about EXORPHIA Inc.'s valuation, stock price, and market status.

Is EXORPHIA Inc. a public or private company?

EXORPHIA Inc. is a private company.

What is the current stock price of EXORPHIA Inc.?

EXORPHIA Inc. is a private company with no public stock price. No recent secondary market data is available.

How much is EXORPHIA Inc. worth (valuation)?

Valuation information for EXORPHIA Inc. is not publicly available.

Can I buy EXORPHIA Inc. stock?

EXORPHIA Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was EXORPHIA Inc.'s last funding round?

EXORPHIA Inc.'s most recent funding round was Grant on December 16, 2024.

Who are the main investors in EXORPHIA Inc.?

Key investors in EXORPHIA Inc. include Keio Innovation Initiative, Coral Capital, D3 LLC.

Will EXORPHIA Inc. IPO soon?

No public IPO plans have been announced for EXORPHIA Inc..

How can I track EXORPHIA Inc. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor EXORPHIA Inc.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersTokyo
Employee Range8
Year Founded2019
Last FundingDec 16, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?